Bausch Health Companies Inc. (BHC) announced that its dermatology subsidiary, Ortho Dermatologics, has made the Biafine® Skin Recovery Emulsion available for purchase through select online channels in the United States, including Amazon. The launch expands BHC’s dermatology distribution network, allowing patients and dermatology practices to access the product directly online or through Ortho Dermatologics Direct for in‑office use.
Biafine, first introduced in France in 1971, is a lightweight emulsion marketed as a barrier‑supporting, hydrating formula suitable for dry, sensitive, or stressed skin. The product has long been trusted by professionals and consumers alike, a sentiment echoed by Tom Stern, Vice President and General Manager of Ortho Dermatologics, who said, "We are proud to offer dermatology practices and patients access to a formula that has earned the trust of both professionals and consumers for decades."
The online launch is part of BHC’s broader strategy to expand its reach in the aesthetics and dermatology markets. By adding e‑commerce to its sales mix, BHC aims to broaden market penetration and improve convenience for both consumers and practitioners, potentially driving incremental revenue growth in a competitive skincare market.
BHC’s dermatology segment, which includes Ortho Dermatologics, is one of several business units that make up the company’s overall segment performance. While the fact‑check report does not provide specific financial figures for the segment, the launch represents a notable operational milestone that could enhance the segment’s sales channels and support BHC’s goal of increasing market share in the dermatology space.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.